Successful Treatment of Refractory IgA‐Mediated Autoimmune Hemolytic Anemia With Bortezomib

ABSTRACT Introduction IgA‐mediated autoimmune hemolytic anemia (AIHA) is a rare condition associated with severe hemolysis and limited therapeutic response. Bortezomib, a proteasome inhibitor, targets plasma cells responsible for autoantibody production. Here, we describe a case of refractory IgA‐me...

Description complète

Détails bibliographiques

Auteurs principaux:	Silvia Neri, Corien L. Eckhardt, Boukje M. Beuger, Folman Folman, Eva Rettenbacher, Hanke L. Matlung, Taco W. Kuijpers, Josephine M. I. Vos, Robin vanBruggen
Format:	Artigo
Langue:	Inglês
Publié:	Wiley 2025-12-01
Collection:	eJHaem
Accès en ligne:	https://doi.org/10.1002/jha2.70162
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!